BRAF and thyroid gland carcinoma: Current treatment protocols for thyroid cancer primarily rely on surgery, radioactive iodine therapy, and thyroid hormone suppression, with targeted therapies considered for patients with progressive or iodine-refractory disease Kaplan–Meier survival analysis indicated that lower expression of BRAF and PIK3 CA is associated with poorer overall survival, while other genes did not show significant differences.